HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Remoxipride, a selective antagonist of dopamine D2 receptors, in the treatment of delusional psychoses].

Abstract
Remoxipride, a substituted benzamide, is a new antipsychotic agent which differs from classical neuroleptics in several ways. It has a selective action on the dopamine D2 receptors in the brain and little effect on a variety of other receptor types including serotonin, noradrenaline, acetylcholine and histamine receptors. This implies advantages over classical neuroleptics which have less selective modes of action and subsequently increased propensities to cause side effects. The pharmacokinetics of remoxipride are uncomplicated. The drug is rapidly absorbed, plasma levels increase with dose, and elimination is via urinary excretion. No clinically significant drug interactions have been found. Remoxipride has been shown to be as effective in the treatment of schizophrenic patients as haloperidol in both short and long term double-blind trials. Both positive and negative symptoms are improved. However, remoxipride shows advantages over haloperidol in that the incidences of extrapyramidal symptoms and increased plasma prolactin concentrations are lower in remoxipride recipients. There are no clinically relevant adverse effects on chemistry, haematology or cardiovascular variables.
AuthorsT Lewander, S E Westerberg, S O Ogren, C Von Bahr, C Köhler
JournalL'Encephale (Encephale) 1990 Mar-Apr Vol. 16 Issue 2 Pg. 153-7 ISSN: 0013-7006 [Print] France
Vernacular TitleRémoxipride, antagoniste sélectif des récepteurs dopaminergiques D2, dans le traitement des psychoses délirantes.
PMID1972054 (Publication Type: Clinical Trial, English Abstract, Journal Article, Review)
Chemical References
  • Antipsychotic Agents
  • Benzamides
  • Remoxipride
Topics
  • Adult
  • Antipsychotic Agents (adverse effects, pharmacology, therapeutic use)
  • Benzamides (adverse effects, pharmacology, therapeutic use)
  • Clinical Trials as Topic
  • Delusions (drug therapy)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Remoxipride
  • Schizophrenia (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: